# OnCo record plitidepsin (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/plitidepsin/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "plitidepsin" ;
  schema:name "Plitidepsin"@en ;
  schema:alternateName "Dehydrodidemnin B"@en, "Aplidin" ;
  schema:description "Plitidepsin is a chemotherapy derived from a Mediterranean sea squirt, approved in Australia in 2018 with dexamethasone for multiple myeloma after several other treatments; the European regulator refused it, and it drew attention in 2021 as a possible COVID-19 antiviral."@en ;
  schema:url <https://onco.cc/drugs/plitidepsin/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Plitidepsin> ;
  schema:citation <https://en.wikipedia.org/wiki/Plitidepsin>, <https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL505124> ;
  onco:status "established" ;
  onco:tag "gap-fill", "chembl-universe" ;
  onco:modality "Marine-derived cyclic depsipeptide (small molecule), intravenous" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:targets <https://onco.cc/targets/eef2/> ;
  onco:drugs <https://onco.cc/drugs/dexamethasone/> ;
  onco:companies <https://onco.cc/companies/pharmamar/> ;
  onco:trials <https://onco.cc/trials/nct01102426/>, <https://onco.cc/trials/nct00229203/>, <https://onco.cc/trials/nct01876043/> .